{"id":"https://openalex.org/W4244808133","doi":"https://doi.org/10.1158/1538-7445.sabcs18-ct028","title":"Abstract CT028: Drug-drug interaction potential of EZH2 inhibitor tazemetostat (TAZ)","display_name":"Abstract CT028: Drug-drug interaction potential of EZH2 inhibitor tazemetostat (TAZ)","publication_year":2019,"publication_date":"2019-07-01","ids":{"openalex":"https://openalex.org/W4244808133","doi":"https://doi.org/10.1158/1538-7445.sabcs18-ct028"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.sabcs18-ct028","doi":"https://doi.org/10.1158/1538-7445.sabcs18-ct028","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.sabcs18-ct028","pdf_url":null,"source":{"id":"https://openalex.org/S59378366","display_name":"Clinical Trials","issn_l":"1740-7745","issn":["1740-7745","1740-7753"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","jufo-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Trials","raw_type":"proceedings-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5075692970","display_name":"Jennifer Effie Amengual","orcid":"https://orcid.org/0000-0003-4117-2469","observed_orcids":["https://orcid.org/0000-0003-4117-2469"]},"institutions":[{"id":"https://openalex.org/I2799503643","display_name":"Columbia University Irving Medical Center","ror":"https://ror.org/01esghr10","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799503643"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jennifer E. Amengual","raw_affiliation_strings":["Center for Lymphoid Malignancies, Department of Medicine, Columbia University Medical Center, New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Lymphoid Malignancies, Department of Medicine, Columbia University Medical Center, New York, NY","institution_ids":["https://openalex.org/I2799503643"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006913373","display_name":"Gary K. Schwartz","orcid":"https://orcid.org/0000-0003-1813-5061","observed_orcids":["https://orcid.org/0000-0003-1813-5061"]},"institutions":[{"id":"https://openalex.org/I2799503643","display_name":"Columbia University Irving Medical Center","ror":"https://ror.org/01esghr10","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799503643"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gary K. Schwartz","raw_affiliation_strings":["Herbert Irving Comprehensive Care Center, Columbia University Irving Medical Center, New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Herbert Irving Comprehensive Care Center, Columbia University Irving Medical Center, New York, NY","institution_ids":["https://openalex.org/I2799503643"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048094128","display_name":"Lora Incl\u00e1n","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4390039223","display_name":"University of Arizona Cancer Center","ror":"https://ror.org/04tvx8690","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4390039223"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lora Inclan","raw_affiliation_strings":["University of Arizona Cancer Center, Tucson, AZ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Arizona Cancer Center, Tucson, AZ","institution_ids":["https://openalex.org/I4390039223"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066974016","display_name":"Abhijeet Kumar","orcid":"https://orcid.org/0000-0003-3617-0741","observed_orcids":["https://orcid.org/0000-0003-3617-0741"]},"institutions":[{"id":"https://openalex.org/I4390039223","display_name":"University of Arizona Cancer Center","ror":"https://ror.org/04tvx8690","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4390039223"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Abhijeet Kumar","raw_affiliation_strings":["University of Arizona Cancer Center, Tucson, AZ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Arizona Cancer Center, Tucson, AZ","institution_ids":["https://openalex.org/I4390039223"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065099481","display_name":"Patricia Robles-Medina","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4390039223","display_name":"University of Arizona Cancer Center","ror":"https://ror.org/04tvx8690","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4390039223"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Patricia Robles-Medina","raw_affiliation_strings":["University of Arizona Cancer Center, Tucson, AZ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Arizona Cancer Center, Tucson, AZ","institution_ids":["https://openalex.org/I4390039223"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006994766","display_name":"Shahnaz V. Singh-Kandah","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2799503643","display_name":"Columbia University Irving Medical Center","ror":"https://ror.org/01esghr10","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799503643"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Shahnaz Singh-Kandah","raw_affiliation_strings":["Herbert Irving Comprehensive Care Center, Columbia University Irving Medical Center, New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Herbert Irving Comprehensive Care Center, Columbia University Irving Medical Center, New York, NY","institution_ids":["https://openalex.org/I2799503643"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071070987","display_name":"Benjamin B. Suttle","orcid":"https://orcid.org/0000-0002-9521-1884","observed_orcids":["https://orcid.org/0000-0002-9521-1884"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Benjamin Suttle","raw_affiliation_strings":["qPharmetra, Raleigh, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"qPharmetra, Raleigh, NC","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016599849","display_name":"Melissa Jo Beelen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210109703","display_name":"Epizyme (United States)","ror":"https://ror.org/01mmhvx47","country_code":"US","type":"company","lineage":["https://openalex.org/I4210109703"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Melissa Beelen","raw_affiliation_strings":["Epizyme, Cambridge, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Epizyme, Cambridge, MA","institution_ids":["https://openalex.org/I4210109703"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5073861459","display_name":"Daniel Oscar Persky","orcid":"https://orcid.org/0000-0002-3483-2142","observed_orcids":["https://orcid.org/0000-0002-3483-2142"]},"institutions":[{"id":"https://openalex.org/I4390039223","display_name":"University of Arizona Cancer Center","ror":"https://ror.org/04tvx8690","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4390039223"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Daniel Persky","raw_affiliation_strings":["University of Arizona Cancer Center, Tucson, AZ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Arizona Cancer Center, Tucson, AZ","institution_ids":["https://openalex.org/I4390039223"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":4150,"currency":"USD","value_usd":4150},"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":"CT028","last_page":"CT028"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.9854000210762024,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.9854000210762024,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10269","display_name":"Epigenetics and DNA Methylation","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/tazemetostat","display_name":"tazemetostat","score":0.9990000128746033},{"id":"https://openalex.org/keywords/ezh2-inhibitors","display_name":"EZH2 inhibitors","score":0.9620000123977661},{"id":"https://openalex.org/keywords/drug-drug-interactions","display_name":"drug-drug interactions","score":0.9319999814033508},{"id":"https://openalex.org/keywords/fluconazole","display_name":"fluconazole","score":0.7599999904632568},{"id":"https://openalex.org/keywords/cyp3a-inhibition","display_name":"CYP3A inhibition","score":0.8790000081062317},{"id":"https://openalex.org/keywords/repaglinide","display_name":"repaglinide","score":0.8579999804496765},{"id":"https://openalex.org/keywords/omeprazole","display_name":"omeprazole","score":0.878000020980835},{"id":"https://openalex.org/keywords/cyp2c8","display_name":"CYP2C8","score":0.8870000243186951},{"id":"https://openalex.org/keywords/cyp2c19","display_name":"CYP2C19","score":0.9980000257492065},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.9570000171661377},{"id":"https://openalex.org/keywords/advanced-solid-tumors","display_name":"advanced solid tumors","score":0.8029999732971191},{"id":"https://openalex.org/keywords/b-cell-non-hodgkin-lymphoma","display_name":"B-cell non-Hodgkin lymphoma","score":0.9860000014305115},{"id":"https://openalex.org/keywords/treatment-emergent-adverse-events","display_name":"treatment-emergent adverse events","score":0.7070000171661377},{"id":"https://openalex.org/keywords/oral-anticancer-drugs","display_name":"oral anticancer drugs","score":0.453000009059906}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8651888370513916},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.6637730002403259},{"id":"https://openalex.org/C22979827","wikidata":"https://www.wikidata.org/wiki/Q5137311","display_name":"Cmax","level":3,"score":0.6392074823379517},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5783972144126892},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5476955771446228},{"id":"https://openalex.org/C2777498785","wikidata":"https://www.wikidata.org/wiki/Q422210","display_name":"Omeprazole","level":2,"score":0.5405195951461792},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.4847669005393982},{"id":"https://openalex.org/C2780873365","wikidata":"https://www.wikidata.org/wiki/Q496812","display_name":"Leukopenia","level":3,"score":0.4728439450263977},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.469009131193161},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.46874740719795227},{"id":"https://openalex.org/C2777063308","wikidata":"https://www.wikidata.org/wiki/Q1435822","display_name":"Neutropenia","level":3,"score":0.430361270904541},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.22450262308120728}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.sabcs18-ct028","doi":"https://doi.org/10.1158/1538-7445.sabcs18-ct028","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.sabcs18-ct028","pdf_url":null,"source":{"id":"https://openalex.org/S59378366","display_name":"Clinical Trials","issn_l":"1740-7745","issn":["1740-7745","1740-7753"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","jufo-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Trials","raw_type":"proceedings-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9907000064849854,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4393114610","https://openalex.org/W3083297516","https://openalex.org/W2485794975","https://openalex.org/W4410260359","https://openalex.org/W4411114772","https://openalex.org/W4289917494","https://openalex.org/W2506244668","https://openalex.org/W3089053322","https://openalex.org/W7166824595","https://openalex.org/W3133864305"],"abstract_inverted_index":{"TAZ,":[0,374],"a":[1,38,248],"selective,":[2],"oral":[3],"EZH2":[4,401],"inhibitor,":[5],"is":[6,257],"in":[7,35,44,94,188,197,203,209,225,252],"the":[8,15,189,245,253,354,409],"phase":[9,39],"2":[10],"clinical":[11],"investigation":[12],"stage":[13],"for":[14,83,412],"treatment":[16,192,215],"of":[17,31,163,166,247,255,266,291,328,366,400,408],"advanced":[18],"solid":[19],"tumors":[20],"(AdvST)":[21],"and":[22,91,112,123,148,156,200,240,295],"B-cell":[23],"non-Hodgkin":[24],"lymphoma":[25],"(NHL).":[26],"Drug-drug":[27,397],"interaction":[28,398],"(DDI)":[29],"potential":[30,399],"TAZ":[32,55,98,127,256,292,306],"was":[33,73,180,194],"investigated":[34],"study":[36,43,259],"EZH-105,":[37],"1,":[40,146],"open-label,":[41],"2-part":[42],"adults":[45],"with":[46],"AdvST":[47],"or":[48],"NHL.":[49],"In":[50,243],"Part":[51,95,198,204,210],"A,":[52],"patients":[53,171],"received":[54,97],"400":[56,71],"mg":[57,64,72,100,111,117,134],"twice-daily":[58],"(BID)":[59],"days":[60,78,89,137,145,196,202],"1-24,":[61],"then":[62],"800":[63,99],"BID":[65,101],"continuously.":[66],"Moderate":[67],"CYP3A":[68],"inhibitor":[69,402],"fluconazole":[70,267,276],"administered":[74,119],"once":[75],"daily":[76],"(QD)":[77],"16-19.":[79],"Serial":[80,139],"blood":[81,140],"samples":[82,141],"pharmacokinetic":[84,184],"analysis":[85],"were":[86,118,142,151,172,223],"collected":[87,143],"on":[88,120,129,144,154,268,293,330],"15":[90,272],"19.":[92,149],"Patients":[93],"B":[96],"continuously":[102],"starting":[103],"day":[104,121,130],"2.":[105],"The":[106,228,264,289,326],"CYP2C8":[107],"probe":[108,114],"repaglinide":[109],"0.25":[110],"CYP2C19":[113],"omeprazole":[115],"20":[116,133],"1":[122,124,300],"hour":[125],"following":[126],"administration":[128],"16.":[131],"Omeprazole":[132],"QD":[135],"continued":[136],"17-19.":[138],"16,":[147],"DDIs":[150],"evaluated":[152],"based":[153],"AUC":[155],"Cmax.":[157],"Other":[158],"primary":[159],"endpoints":[160],"included":[161,235],"safety":[162],"TAZ.":[164],"As":[165],"August":[167],"14,":[168],"2018,":[169],"27":[170],"enrolled":[173],"(n=17":[174],"AdvST,":[175],"n=10":[176],"NHL).":[177],"Median":[178,191],"age":[179],"60":[181],"years.":[182],"Preliminary":[183],"results":[185],"are":[186],"displayed":[187],"Table.":[190],"exposure":[193],"70":[195],"A":[199],"57":[201],"B.":[205,288,325],"Two":[206],"patients,":[207],"both":[208],"B,":[211],"discontinued":[212],"due":[213],"to":[214,333],"emergent":[216],"adverse":[217],"events":[218],"(TEAEs).":[219],"Grade":[220],"\u22653":[221],"TEAEs":[222,232],"reported":[224],"12":[226],"patients.":[227],"most":[229],"frequent":[230],"treatment-related":[231],"(any":[233],"grade)":[234],"diarrhea":[236],"(n=6),":[237,239],"fatigue":[238],"nausea":[241],"(n=3).":[242],"conclusion,":[244],"likelihood":[246],"clinically":[249],"significant":[250],"DDI":[251],"presence":[254],"minimal.Table.Preliminary":[258],"EZH-105":[260],"PK":[261],"resultsPart":[262],"A.":[263],"effect":[265,290,327],"TAZParameterTAZ":[269],"alone":[270],"Day":[271,277,299,307,335,341],"Mean":[273,279,301,309,337,343],"(%CV)TAZ":[274,338],"+":[275,297,303,305,339],"19":[278,342],"(%CV)TAZ,":[280,344],"n=14Cmax,":[281],"ng/ml426":[282],"(95)968":[283],"(80)AUC0-12h,":[284],"ng*h/mL1590":[285],"(81)5180":[286],"(66)Part":[287],"REP":[294],"OMPREP":[296],"OMP":[298,304,329,334,340],"(%CV)REP":[302],"16":[308,336],"(%CV)REP,":[310],"n=12Cmax,":[311,318],"ng/ml5":[312],"(109)10":[313],"(78)AUC0-7h,":[314],"ng*h/mL9":[315],"(110)17":[316],"(65)OMP,":[317],"ng/ml263":[319],"(266)220":[320],"(250)AUC0-7h,":[321],"ng*h/mL677":[322],"(340)558":[323],"(231)Part":[324],"TAZTAZ":[331],"prior":[332],"n=9Cmax,":[345],"ng/ml613":[346],"(91)663":[347],"(68)AUC0-12h,":[348],"ng*h/mL2200":[349],"(58)2820":[350],"(62)AUC,":[351],"area":[352],"under":[353],"concentration":[355],"curve;":[356],"CI,":[357],"confidence":[358],"interval;":[359],"Cmax,":[360],"maximum":[361],"plasma":[362],"concentration;":[363],"CV,":[364],"coefficient":[365],"variation;":[367],"REP,":[368],"repaglinide;":[369],"OMP,":[370],"omeprazole;":[371],"PK,":[372],"pharmacokinetic;":[373],"tazemetostat.Citation":[375],"Format:":[376],"Jennifer":[377],"E.":[378],"Amengual,":[379],"Gary":[380],"K.":[381],"Schwartz,":[382],"Lora":[383],"Inclan,":[384],"Abhijeet":[385],"Kumar,":[386],"Patricia":[387],"Robles-Medina,":[388],"Shahnaz":[389],"Singh-Kandah,":[390],"Benjamin":[391],"Suttle,":[392],"Melissa":[393],"Beelen,":[394],"Daniel":[395],"Persky.":[396],"tazemetostat":[403],"(TAZ)":[404],"[abstract].":[405],"In:":[406],"Proceedings":[407],"American":[410],"Association":[411],"Cancer":[413,427],"Research":[414],"Annual":[415],"Meeting":[416],"2019;":[417],"2019":[418],"Mar":[419],"29-Apr":[420],"3;":[421],"Atlanta,":[422],"GA.":[423],"Philadelphia":[424],"(PA):":[425],"AACR;":[426],"Res":[428],"2019;79(13":[429],"Suppl):Abstract":[430],"nr":[431],"CT028.":[432]},"counts_by_year":[],"updated_date":"2026-10-30T12:39:25.321706","created_date":"2022-05-12T00:00:00"}